Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Johnson & Johnson JNJ
$226.71
▼ -1.77%
($-4.09)
Index member:
S&P 500
Dow Jones
Open
$230.77
Prev Close
$230.80
Day Range
$226.44 – $232.14
52W Range
$147.33 – $251.71
Market Cap
$539.84B
P/E (TTM)
25.94
Beta
0.26
Div Yield
2.32%
EPS (TTM)
$8.65
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1944-09-25 |
| Shares Out. | 2,408,610,000 |
| Website | jnj.com/ ↗ |
| Phone | 17325242455 |
Johnson & Johnson is a publicly traded company under the ticker symbol JNJ on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
32 analysts (2026-05-01)
📰 Latest News for JNJ
Bonds Now Make Up Just 8% of the Average Portfolio. What Replaced Them
Kiplinger’s May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
Why Keeping Emergency Cash in Checking Costs You $15,000 Over a Decade
Dividend Champion, Contender, And Challenger Highlights: Week Of May 17
Soros Fund Management reports share stake in Mastercard, Berkshire Hathaway & J&J
What Retirement Really Looks Like at 64 With $2.4 Million and a Father Moving Into the Guest Room Next Year
If You Have $480,000 Saved at 67 and Just Sold a Restaurant for $1.1 Million Cash, Here Is the Income Plan That Actually Holds